S100A13 and central nervous system cancer: Specifically, S100A8 and S100A9 were expressed in myeloid cells, S100A10 and S100A11 in various cell types, especially in glioma tumor cells, and S100A13 and S100A16 in vascular cells (Supplementary Figure 1C).